Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection

2014 ◽  
Vol 16 (5) ◽  
pp. 797-801 ◽  
Author(s):  
M. Takahata ◽  
S. Hashino ◽  
M. Onozawa ◽  
A. Shigematsu ◽  
J. Sugita ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document